Zika Virus-A Reemerging Neurotropic Arbovirus Associated with Adverse Pregnancy Outcomes and Neuropathogenesis
- PMID: 38392915
- PMCID: PMC10892292
- DOI: 10.3390/pathogens13020177
Zika Virus-A Reemerging Neurotropic Arbovirus Associated with Adverse Pregnancy Outcomes and Neuropathogenesis
Abstract
Zika virus (ZIKV) is a reemerging flavivirus that is primarily spread through bites from infected mosquitos. It was first discovered in 1947 in sentinel monkeys in Uganda and has since been the cause of several outbreaks, primarily in tropical and subtropical areas. Unlike earlier outbreaks, the 2015-2016 epidemic in Brazil was characterized by the emergence of neurovirulent strains of ZIKV strains that could be sexually and perinatally transmitted, leading to the Congenital Zika Syndrome (CZS) in newborns, and Guillain-Barre Syndrome (GBS) along with encephalitis and meningitis in adults. The immune response elicited by ZIKV infection is highly effective and characterized by the induction of both ZIKV-specific neutralizing antibodies and robust effector CD8+ T cell responses. However, the structural similarities between ZIKV and Dengue virus (DENV) lead to the induction of cross-reactive immune responses that could potentially enhance subsequent DENV infection, which imposes a constraint on the development of a highly efficacious ZIKV vaccine. The isolation and characterization of antibodies capable of cross-neutralizing both ZIKV and DENV along with cross-reactive CD8+ T cell responses suggest that vaccine immunogens can be designed to overcome these constraints. Here we review the structural characteristics of ZIKV along with the evidence of neuropathogenesis associated with ZIKV infection and the complex nature of the immune response that is elicited by ZIKV infection.
Keywords: ADE; CZS; Dengue; Zika; cross-neutralization; neuropathology; pregnancy.
Conflict of interest statement
The authors declare no conflicts of interest.
Figures
![Figure 1](https://www.ncbi.nlm.nih.gov/pmc/articles/instance/10892292/bin/pathogens-13-00177-g001.gif)
![Figure 2](https://www.ncbi.nlm.nih.gov/pmc/articles/instance/10892292/bin/pathogens-13-00177-g002.gif)
![Figure 3](https://www.ncbi.nlm.nih.gov/pmc/articles/instance/10892292/bin/pathogens-13-00177-g003.gif)
Similar articles
-
Impact of prior dengue virus infection on Zika virus infection during pregnancy in marmosets.Sci Transl Med. 2023 Jun 7;15(699):eabq6517. doi: 10.1126/scitranslmed.abq6517. Epub 2023 Jun 7. Sci Transl Med. 2023. PMID: 37285402
-
Hide and Seek: The Interplay Between Zika Virus and the Host Immune Response.Front Immunol. 2021 Oct 21;12:750365. doi: 10.3389/fimmu.2021.750365. eCollection 2021. Front Immunol. 2021. PMID: 34745123 Free PMC article. Review.
-
Sustained Specific and Cross-Reactive T Cell Responses to Zika and Dengue Virus NS3 in West Africa.J Virol. 2018 Mar 14;92(7):e01992-17. doi: 10.1128/JVI.01992-17. Print 2018 Apr 1. J Virol. 2018. PMID: 29321308 Free PMC article.
-
Humoral Immune Responses Against Zika Virus Infection and the Importance of Preexisting Flavivirus Immunity.J Infect Dis. 2017 Dec 16;216(suppl_10):S906-S911. doi: 10.1093/infdis/jix513. J Infect Dis. 2017. PMID: 29267924 Free PMC article. Review.
-
Dengue Virus Envelope Dimer Epitope Monoclonal Antibodies Isolated from Dengue Patients Are Protective against Zika Virus.mBio. 2016 Jul 19;7(4):e01123-16. doi: 10.1128/mBio.01123-16. mBio. 2016. PMID: 27435464 Free PMC article.
References
-
- Buathong R., Hermann L., Thaisomboonsuk B., Rutvisuttinunt W., Klungthong C., Chinnawirotpisan P., Manasatienkij W., Nisalak A., Fernandez S., Yoon I.K., et al. Detection of Zika Virus Infection in Thailand, 2012–2014. Am. J. Trop. Med. Hyg. 2015;93:380–383. doi: 10.4269/ajtmh.15-0022. - DOI - PMC - PubMed
Publication types
Grants and funding
LinkOut - more resources
Full Text Sources
Research Materials